0000727273 2025-01-01 2025-12-31 0000727273 2026-03-25 0000727273 2025-06-30 0000727273 cdzi:DepositarySharesMember 2025-01-01 2025-12-31 0000727273 cdzi:CommonStockParValue0.01PerShareMember 2025-01-01 2025-12-31 shares iso4217:USD true 0000727273 FY 10-K/A true 2025-12-31 --12-31 2025 false 001-40579 Cadiz Inc. DE 77-0313235 550 S. Hope Street, Suite 2850 Los Angeles CA 90071 (213) 271-1600 Common Stock, par value $0.01 per share CDZI   NASDAQ Depositary Shares CDZIP NASDAQ No No Yes Yes Non-accelerated Filer true false false false false 165039069 83424366 Portions of the Registrant’s definitive Proxy Statement to be filed for its 2026 Annual Meeting of Stockholders are incorporated by reference into Part III of this Report. The Registrant is not incorporating by reference any other documents within this Annual Report on Form 10-K except those footnoted in Part IV under the heading “Item 15. Exhibits and Financial Statement Schedules”. This Amendment No. 1 (“Amendment No. 1”) to the Annual Report on Form 10-K of Cadiz Inc. (the “Company”) for the year ended December 31, 2025, as filed with the U.S. Securities and Exchange Commission on March 31, 2026 (the “Original Form 10-K”), is being filed for the sole purpose of correcting the Consent of Independent Registered Public Accounting Firm (the “Consent”) filed as Exhibit 23.1 to the Original Form 10-K. The filed Consent contained a typographical error in the date of the report referenced therein, which was incorrectly stated as March 30, 2026 instead of March 31, 2026, the date included in the manually signed Consent. A corrected Consent is filed as Exhibit 23.1 attached hereto.Except as otherwise expressly noted herein, this Amendment No. 1 does not modify or update in any way the disclosures in, or exhibits to, the Original Form 10-K, nor does it reflect events occurring after the filing of the Original Form 10-K. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Form 10-K.In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), certifications by the Company’s principal executive officer and principal financial officer are filed herewith as exhibits to this Amendment No. 1 pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act. As no financial statements have been included in this Amendment No. 1 and it does not contain or amend any disclosure with respect to Items 307 or 308 of Regulation S-K, paragraphs 3, 4, and 5 of the certifications have been omitted. The Company is not including certifications pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) as no financial statements are being filed with this Amendment No. 1.